SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury

Independent DSMB reports zero device-related safety issues
Supports potential clinical benefit
Trial sample size re-estimated to strengthen statistical power

Read more at globenewswire.com